San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Claritas Rx is raising $13,637,165.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Mike Fitzgibbons played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Claritas Rx

Claritas Rx started with a simple vision: to tangibly improve how biopharmaceutical manufacturers understand their specialty product performance in the marketplace. Since then, Claritas Rx has grown from a small channel data consultancy to become a pioneer in patient-level data integration and analytics for the biopharmaceutical industry. Today, our customers range from small biotechnology companies launching their first specialty product to large global manufacturers with a strong portfolio of specialty products.

To learn more about Claritas Rx, visit http://www.claritasrx.com/

Contact:
Mike Fitzgibbons, Chief Executive Officer
415-689-7180
mfitzgibbons@claritasrx.com
https://www.linkedin.com/in/mfitzgibbons/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved